InSilico Medicine Cayman TopCo
Status: Publicly traded
Direct answer
InSilico Medicine Cayman TopCo is publicly traded on HKSE under the ticker 3696.HK.
InSilico Medicine Cayman TopCo engages in applying artificial intelligence (AI) solutions to drug discovery and development by leveraging its proprietary platforms. The company offers Pharma.AI, an AI-powered drug discovery and development platform offering new target identification, small molecule generation, and clinical outcome prediction services. Its pipeline covers solutions for fibrosis, oncology, immunology,...
Can you invest in InSilico Medicine Cayman TopCo?
Yes. InSilico Medicine Cayman TopCo trades publicly on HKSE as 3696.HK.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for InSilico Medicine Cayman TopCo
Detailed equity research is provided by MarketSnap.